NCT03826134View on ClinicalTrials.gov

A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy Subjects

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Parkinson Disease
Interventions
DRUG

[11C]PXT012253

Single intravenous bolus injection. The injected amount will be less than 5 μg. The radioactive dose is approximately 400 MBq per 70 kg body weight.

Trial Locations (1)

Unknown

Karolinska Institute, Dept. of Clinical Neuroscience, Stockholm

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT03826134 - A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy Subjects | Biotech Hunter | Biotech Hunter